-
Heart-Valve-Surgery.Com and Medtronic Launch Novel “Aortic Stenosis Patient Activation Platform” to Empower Patients
LOS ANGELES, April 25, 2024 /PRNewswire/ — Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from Medtronic, a global leader in healthcare technology, today launched the “Aortic Stenosis Patient Activation Platform”, an end-to-end digital platform for patient awareness, patient education, and patient activation specific to aortic valve stenosis. Continue Reading Aortic Valve
-
GenEmbryomics and Progenesis Announce Strategic Partnership to Transform IVF Testing
MELBOURNE, Australia and LA JOLLA, Calif., April 24, 2024 /PRNewswire/ — In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited, a pioneering provider of advanced genetic testing services for embryos, and Progenesis Inc, a leading provider of preimplantation genetic testing for in vitro fertilization (IVF), today announced a groundbreaking collaboration to
-
RTI International and Nested Knowledge Announce Collaboration to Enhance Life Science and Healthcare Research
Strategic collaboration follows RTI’s equity investment in the technology start-up RESEARCH TRIANGLE PARK, N.C., April 24, 2024 /PRNewswire/ — RTI International, a nonprofit research institute, and Nested Knowledge, a platform for AI-driven evidence synthesis, systematic literature review and meta-analysis, formally announce a strategic collaboration between the two organizations. The Collaboration Agreement will provide clients with
-
Penstock Partners with Paradigm to Lower Unnecessary Spend on Surgical Implants
WILLIAMSVILLE, N.Y., April 23, 2024 /PRNewswire/ — Penstock Group announced today a partnership with Paradigm, an accountable specialty care management organization and developer of a proprietary payment integrity program assuring accurate payments for surgical implant claims. Penstock, a leader in the healthcare payment integrity space focused on delivering innovative and niche results, saw a unique opportunity to
-
Clinical Microbiomics Launches Advanced Long-Read 16S, ITS, 18S, Isolate, and Metagenomics Sequencing Services
Offering Unparalleled Resolution and Quality in Microbial Analysis COPENHAGEN, Denmark, April 23, 2024 /PRNewswire/ — Clinical Microbiomics, a leader in microbiome analysis, announces the launch of its advanced long-read sequencing services. Tailored to meet the stringent requirements of academic, clinical, and industrial researchers, the expanded offerings deliver unmatched insights into microbial communities, featuring the industry’s highest
-
Trialize Announces Launch of TDOM: Bridging Interoperability in Clinical Trials
ZUG, Switzerland, April 22, 2024 /PRNewswire/ — Trialize (https://trialize.io) is proud to unveil the Trial Data Object Model (TDOM), an innovative open-source framework designed to enhance interoperability among various e-clinical systems. Tailored for clinical trials, TDOM aims to standardize data exchange, boosting efficiency, accuracy, and the speed of data sharing. Continue Reading Trialize Announces Launch
-
Prescient Healthcare Group Appoints Two New Members to its Board of Directors
LONDON, April 19, 2024 /PRNewswire/ — Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient’s global mission. Dr. Luke Solon joined us in 2021 and leads
-
World IBS Day – April 19th: Raising Awareness for Everyone with IBS
Debunking myths about Irritable Bowel Syndrome TORONTO, April 18, 2024 /PRNewswire/ — IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating, constipation, and diarrhea. Misunderstood and stigmatized, this condition significantly impacts individuals’ quality of life. World IBS Day 2024 includes awareness for patients with IBS. World IBS Day is now recognized in
-
Stramsen Biotech Joins Elite Class of Unicorns at $6.5 Billion Valuation and a Potential Reverse Merger Deal
Stramsen is negotiating a potential acquisition and/or a reverse merger with several US-based publicly traded companies. HOUSTON, April 18, 2024 /PRNewswire/ — More than three years after establishment, Stramsen Biotech, Inc, is one of the leading plant-based biotech start-up companies in the world. After initial valuation in 2023, it has now officially been valued at $6.5 Billion,
-
InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance
DELFT, Netherlands, April 17, 2024 /PRNewswire/ — InnoGI Technologies (formerly The TIM Company) is pleased to announce an exciting, market-driven collaboration with Simulations Plus to combine its TIM Technology, part of the InnoGI SurroGUT™ platform, with the GastroPlus® and ADMET Predictor® modelling software offered by Simulations Plus. Continue Reading InnoGI Technologies Understanding drug behavior following
